1.
Mesti T, Ebert Moltara M, Boc M, Reberšek M, Ocvirk J. Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience. RO [Internet]. 2015 Feb. 11 [cited 2022 Jan. 29];49(1). Available from: https://www.radioloncol.com/index.php/ro/article/view/2010